<p>RNS 編號：4645B Assura PLC2025 年 9 月 30 日</p>
<p>2025 年 9 月 30 日</p>
<p>Assura plc（“Assura” 或 “公司”）</p>
<p>股東大會結果</p>
<p>在今天舉行的年度股東大會（“AGM”）之後，Assura 宣佈了提交會議的每項決議的投票結果（如 2025 年 9 月 5 日的股東大會通知中所列）。除第 13 至 16 項決議外，所有決議均已通過，因為 Primary Health Properties PLC 決定目前不需要這些決議。</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>決議</td>
<td>支持</td>
<td>%</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>支持</td>
<td>反對</td>
<td>% 反對</td>
<td>投票總數（佔已發行股本的%）</td>
<td>投票棄權</td>
<td></td>
<td></td>
</tr>
<tr>
<td>1. 接收公司的年度報告和賬目</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>2. 批准董事薪酬政策</td>
<td>3,191,198,870</td>
<td>99.92</td>
<td>2,713,862</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>3. 批准董事薪酬報告</td>
<td>3,191,196,870</td>
<td>99.92</td>
<td>2,714,809</td>
<td>0.08</td>
<td>3,193,911,679 (98.08)</td>
<td>25,609</td>
</tr>
<tr>
<td>4. 重新任命安永會計師事務所為公司的審計師</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>5. 授權審計委員會決定審計師的報酬</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>6. 重新選舉 Jonathan Murphy 為公司的董事</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>7. 重新選舉 Jayne Cottam 為公司的董事</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>8. 重新選舉 Louise Fowler 為公司的董事</td>
<td>3,190,442,909</td>
<td>99.89</td>
<td>3,469,823</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>9. 重新選舉 Jonathan Davies 為公司的董事</td>
<td>3,189,424,843</td>
<td>99.86</td>
<td>4,487,889</td>
<td>0.14</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>10. 重新選舉 Samantha Barrell 為公司的董事</td>
<td>3,190,440,909</td>
<td>99.89</td>
<td>3,471,823</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>11. 重新選舉 Emma Cariaga 為公司的董事</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>12. 重新選舉 Noel Gordon 為公司的董事</td>
<td>3,191,185,999</td>
<td>99.91</td>
<td>2,726,733</td>
<td>0.09</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>13. 授權董事分配股份</td>
<td>24,777,490</td>
<td>0.78</td>
<td>3,169,134,189</td>
<td>99.22</td>
<td>3,193,911,679 (98.08)</td>
<td>25,609</td>
</tr>
<tr>
<td>14. 授權董事放棄優先認購權</td>
<td>13,632,718</td>
<td>0.43</td>
<td>3,180,279,914</td>
<td>99.57</td>
<td>3,193,912,632 (98.08)</td>
<td>24,656</td>
</tr>
<tr>
<td>15. 授權董事在收購或特定資本投資中放棄優先認購權</td>
<td>12,529,192</td>
<td>0.39</td>
<td>3,181,382,387</td>
<td>99.61</td>
<td>3,193,911,579 (98.08)</td>
<td>25,709</td>
</tr>
<tr>
<td>16. 授權市場購買公司自有股份</td>
<td>25,792,609</td>
<td>0.81</td>
<td>3,168,120,123</td>
<td>99.19</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>17. 授權將公司重新註冊為私人公司並採用新章程</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>18. 授權公司在不低於 14 天的通知下召集任何股東大會（除年度股東大會外）</td>
<td>3,190,267,614</td>
<td>99.89</td>
<td>3,645,118</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
</tbody>
</table>
<p>第 1 至 12 項決議作為普通決議通過。第 17 和 18 項決議作為特別決議通過。支持票包括主席酌情投票。</p>
<p>備註：</p>
<p>1. 上述百分比四捨五入至小數點後兩位。</p>
<p>2. 投票棄權在法律上不算作投票，並不計入 “支持” 和 “反對” 決議的比例計算。</p>
<p>3. 截至 2025 年 9 月 26 日下午 6 點，想要在股東大會上投票的股東必須已登記在公司的股東名冊上，Assura 普通股的總髮行量為 3,256,393,191，公司的投票權總數也為 3,256,393,191。</p>
<p>第 17 和 18 項決議的副本，作為公司在上述股東大會上通過的非普通業務決議，已提交給國家存儲機制，並將很快在 https://data.fca.org.uk/#/nsm/nationalstoragemechanism 上提供查閲。</p>
<p>- 結束 -</p>
<p>如需更多信息，請聯繫：</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Assura plc</td>
<td>電話：0161 515 2043</td>
</tr>
<tr>
<td>Orla Ball，法律總顧問<br/>David Purcell，投資者關係總監</td>
<td>郵箱：Investor@assura.co.uk</td>
</tr>
<tr>
<td>FGS Global<br/>Gordon Simpson<br/>Grace Whelan</td>
<td>電話：0207 251 3801<br/>郵箱：Assura-LON@fgsglobal.com</td>
</tr>
</tbody>
</table>
<p>編輯備註</p>
<p>Assura 是英國領先的多元化醫療房地產投資信託。Assura 通過其超過 600 個醫療建築的投資組合，促進更好的健康結果，服務超過六百萬患者。</p>
<p>Assura 是一家總部位於阿爾特林厄姆的英國房地產投資信託，目前是 EPRA* 指數的成分股，並在約翰內斯堡證券交易所有二次上市。截至 2025 年 3 月 31 日，Assura 的投資組合估值為 31 億英鎊，並在為股東創造財務回報和分紅方面有着良好的業績記錄。</p>
<p>在 Assura，我們為健康而建設，作為一家認證的 B Corp，我們致力於將環境、社會和公司治理（ESG）作為我們戰略的核心，創造健康的環境（E）、健康的社區（S）和保持健康的商業（G）。</p>
<p>更多信息請訪問 www.assuraplc.com</p>
<p>*EPRA 是歐洲公共房地產協會的註冊商標。</p>
<p>此信息由 RNS 提供，倫敦證券交易所的新聞服務。RNS 獲得金融行為監管局的批准，作為英國的主要信息提供者。有關使用和分發此信息的條款和條件可能適用。如需更多信息，請聯繫 rns@lseg.com 或訪問 www.rns.com。</p>
<p>RNS 可能會使用您的 IP 地址來確認您是否遵守條款和條件，分析您如何與本次溝通中包含的信息互動，並將此分析以匿名方式與他人分享，作為我們商業服務的一部分。有關 RNS 和倫敦證券交易所如何使用您提供的個人數據的更多信息，請參見我們的隱私政策。END RAGSDEFDSEISELU</p>

<p>Assura plc 於 2025 年 9 月 30 日召開了年度股東大會（AGM），除了第 13 至 16 號決議外，所有決議均已通過。關鍵決議包括批准董事薪酬政策和報告、重新任命安永會計師事務所為審計師，以及重新選舉幾位董事。第 17 和 18 號決議涉及公司的重新註冊和召開股東大會，也已通過。Assura 是英國領先的醫療房地產投資信託（REIT），截至 2025 年 3 月 31 日，其投資組合價值為 31 億英鎊</p>

<p>RNS Number : 4645B Assura PLC 30 September 2025</p>
<div class="lb-trans"><p>RNS 編號：4645B Assura PLC2025 年 9 月 30 日</p>
</div><p>30 September 2025</p>
<div class="lb-trans"><p>2025 年 9 月 30 日</p>
</div><p>Assura plc (&#34;Assura&#34; or the &#34;Company&#34;)</p>
<div class="lb-trans"><p>Assura plc（“Assura” 或 “公司”）</p>
</div><p>Result of AGM</p>
<div class="lb-trans"><p>股東大會結果</p>
</div><p>Following its annual general meeting (&#34;AGM&#34;) held today, Assura announces the results of the poll vote for each of the resolutions submitted to the meeting (as set out in the Notice of the AGM dated 5 September 2025). All resolutions except for resolutions 13 to 16 were passed as Primary Health Properties PLC decided they were not required at the current time.</p>
<div class="lb-trans"><p>在今天舉行的年度股東大會（“AGM”）之後，Assura 宣佈了提交會議的每項決議的投票結果（如 2025 年 9 月 5 日的股東大會通知中所列）。除第 13 至 16 項決議外，所有決議均已通過，因為 Primary Health Properties PLC 決定目前不需要這些決議。</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Resolution</td>
<td>For</td>
<td>%<br/>For</td>
<td>Against</td>
<td>% Against</td>
<td>Total Votes Cast (% of issued share capital)</td>
<td>Votes Withheld</td>
</tr>
<tr>
<td>1. To receive the Company's annual report and accounts</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>2. To approve the Directors' Remuneration Policy</td>
<td>3,191,198,870</td>
<td>99.92</td>
<td>2,713,862</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>3. To approve the Directors' Remuneration Report</td>
<td>3,191,196,870</td>
<td>99.92</td>
<td>2,714,809</td>
<td>0.08</td>
<td>3,193,911,679 (98.08)</td>
<td>25,609</td>
</tr>
<tr>
<td>4. To re-appoint Ernst &amp; Young LLP as auditor of the Company</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>5. To authorise the Audit Committee to determine the auditor's remuneration</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>6. To re-elect Jonathan Murphy as a Director of the Company</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>7. To re-elect Jayne Cottam as a Director of the Company</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>8. To re-elect Louise Fowler as a Director of the Company</td>
<td>3,190,442,909</td>
<td>99.89</td>
<td>3,469,823</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>9. To re-elect Jonathan Davies as a Director of the Company</td>
<td>3,189,424,843</td>
<td>99.86</td>
<td>4,487,889</td>
<td>0.14</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>10. To re-elect Samantha Barrell as a Director of the Company</td>
<td>3,190,440,909</td>
<td>99.89</td>
<td>3,471,823</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>11. To re-elect Emma Cariaga as a Director of the Company</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>12. To re-elect Noel Gordon as a Director of the Company</td>
<td>3,191,185,999</td>
<td>99.91</td>
<td>2,726,733</td>
<td>0.09</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>13. To authorise the Directors to allot shares</td>
<td>24,777,490</td>
<td>0.78</td>
<td>3,169,134,189</td>
<td>99.22</td>
<td>3,193,911,679 (98.08)</td>
<td>25,609</td>
</tr>
<tr>
<td>14. To authorise the Directors to disapply pre-emption rights</td>
<td>13,632,718</td>
<td>0.43</td>
<td>3,180,279,914</td>
<td>99.57</td>
<td>3,193,912,632 (98.08)</td>
<td>24,656</td>
</tr>
<tr>
<td>15. To authorise the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment</td>
<td>12,529,192</td>
<td>0.39</td>
<td>3,181,382,387</td>
<td>99.61</td>
<td>3,193,911,579 (98.08)</td>
<td>25,709</td>
</tr>
<tr>
<td>16. To authorise the market purchase of the Company's own shares</td>
<td>25,792,609</td>
<td>0.81</td>
<td>3,168,120,123</td>
<td>99.19</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>17. To authorise re-registration of the Company as a private company and adopt new articles of association</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>18. To authorise the Company to call any general meeting, other than an annual general meeting, by not less than 14 clear days' notice</td>
<td>3,190,267,614</td>
<td>99.89</td>
<td>3,645,118</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>決議</td>
<td>支持</td>
<td>%</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>支持</td>
<td>反對</td>
<td>% 反對</td>
<td>投票總數（佔已發行股本的%）</td>
<td>投票棄權</td>
<td></td>
<td></td>
</tr>
<tr>
<td>1. 接收公司的年度報告和賬目</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>2. 批准董事薪酬政策</td>
<td>3,191,198,870</td>
<td>99.92</td>
<td>2,713,862</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>3. 批准董事薪酬報告</td>
<td>3,191,196,870</td>
<td>99.92</td>
<td>2,714,809</td>
<td>0.08</td>
<td>3,193,911,679 (98.08)</td>
<td>25,609</td>
</tr>
<tr>
<td>4. 重新任命安永會計師事務所為公司的審計師</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>5. 授權審計委員會決定審計師的報酬</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>6. 重新選舉 Jonathan Murphy 為公司的董事</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>7. 重新選舉 Jayne Cottam 為公司的董事</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>8. 重新選舉 Louise Fowler 為公司的董事</td>
<td>3,190,442,909</td>
<td>99.89</td>
<td>3,469,823</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>9. 重新選舉 Jonathan Davies 為公司的董事</td>
<td>3,189,424,843</td>
<td>99.86</td>
<td>4,487,889</td>
<td>0.14</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>10. 重新選舉 Samantha Barrell 為公司的董事</td>
<td>3,190,440,909</td>
<td>99.89</td>
<td>3,471,823</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>11. 重新選舉 Emma Cariaga 為公司的董事</td>
<td>3,191,210,029</td>
<td>99.92</td>
<td>2,702,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>12. 重新選舉 Noel Gordon 為公司的董事</td>
<td>3,191,185,999</td>
<td>99.91</td>
<td>2,726,733</td>
<td>0.09</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>13. 授權董事分配股份</td>
<td>24,777,490</td>
<td>0.78</td>
<td>3,169,134,189</td>
<td>99.22</td>
<td>3,193,911,679 (98.08)</td>
<td>25,609</td>
</tr>
<tr>
<td>14. 授權董事放棄優先認購權</td>
<td>13,632,718</td>
<td>0.43</td>
<td>3,180,279,914</td>
<td>99.57</td>
<td>3,193,912,632 (98.08)</td>
<td>24,656</td>
</tr>
<tr>
<td>15. 授權董事在收購或特定資本投資中放棄優先認購權</td>
<td>12,529,192</td>
<td>0.39</td>
<td>3,181,382,387</td>
<td>99.61</td>
<td>3,193,911,579 (98.08)</td>
<td>25,709</td>
</tr>
<tr>
<td>16. 授權市場購買公司自有股份</td>
<td>25,792,609</td>
<td>0.81</td>
<td>3,168,120,123</td>
<td>99.19</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>17. 授權將公司重新註冊為私人公司並採用新章程</td>
<td>3,191,208,029</td>
<td>99.92</td>
<td>2,704,703</td>
<td>0.08</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
<tr>
<td>18. 授權公司在不低於 14 天的通知下召集任何股東大會（除年度股東大會外）</td>
<td>3,190,267,614</td>
<td>99.89</td>
<td>3,645,118</td>
<td>0.11</td>
<td>3,193,912,732 (98.08)</td>
<td>24,556</td>
</tr>
</tbody>
</table>
</div><p>Resolutions 1 to 12 were passed as ordinary resolutions. Resolutions 17 and 18 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman.</p>
<div class="lb-trans"><p>第 1 至 12 項決議作為普通決議通過。第 17 和 18 項決議作為特別決議通過。支持票包括主席酌情投票。</p>
</div><p>Notes:</p>
<div class="lb-trans"><p>備註：</p>
</div><p>1. The percentages above are rounded to two decimal places.</p>
<div class="lb-trans"><p>1. 上述百分比四捨五入至小數點後兩位。</p>
</div><p>2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes &#34;For&#34; and &#34;Against&#34; a resolution.</p>
<div class="lb-trans"><p>2. 投票棄權在法律上不算作投票，並不計入 “支持” 和 “反對” 決議的比例計算。</p>
</div><p>3. The total number of Assura ordinary shares in issue as at 6.00 pm on 26 September 2025, the time by which shareholders who wanted to vote at the AGM must have been entered on the Company's register of members, was 3,256,393,191 and the total number of voting rights in the Company was also 3,256,393,191.</p>
<div class="lb-trans"><p>3. 截至 2025 年 9 月 26 日下午 6 點，想要在股東大會上投票的股東必須已登記在公司的股東名冊上，Assura 普通股的總髮行量為 3,256,393,191，公司的投票權總數也為 3,256,393,191。</p>
</div><p>Copies of resolutions 17 and 18, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.</p>
<div class="lb-trans"><p>第 17 和 18 項決議的副本，作為公司在上述股東大會上通過的非普通業務決議，已提交給國家存儲機制，並將很快在 https://data.fca.org.uk/#/nsm/nationalstoragemechanism 上提供查閲。</p>
</div><p>- Ends -</p>
<div class="lb-trans"><p>- 結束 -</p>
</div><p>For more information, please contact:</p>
<div class="lb-trans"><p>如需更多信息，請聯繫：</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Assura plc</td>
<td>Tel: 0161 515 2043</td>
</tr>
<tr>
<td>Orla Ball, General Counsel<br/>David Purcell, Investor Relations Director</td>
<td>Email: Investor@assura.co.uk</td>
</tr>
<tr>
<td>FGS Global<br/>Gordon Simpson<br/>Grace Whelan</td>
<td>Tel: 0207 251 3801<br/>Email: Assura-LON@fgsglobal.com</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Assura plc</td>
<td>電話：0161 515 2043</td>
</tr>
<tr>
<td>Orla Ball，法律總顧問<br/>David Purcell，投資者關係總監</td>
<td>郵箱：Investor@assura.co.uk</td>
</tr>
<tr>
<td>FGS Global<br/>Gordon Simpson<br/>Grace Whelan</td>
<td>電話：0207 251 3801<br/>郵箱：Assura-LON@fgsglobal.com</td>
</tr>
</tbody>
</table>
</div><p>Notes to Editors</p>
<div class="lb-trans"><p>編輯備註</p>
</div><p>Assura is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.</p>
<div class="lb-trans"><p>Assura 是英國領先的多元化醫療房地產投資信託。Assura 通過其超過 600 個醫療建築的投資組合，促進更好的健康結果，服務超過六百萬患者。</p>
</div><p>A UK REIT based in Altrincham, Assura is currently a constituent of the EPRA* index and has a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's portfolio was valued at £3.1 billion and has a strong track record of growing financial returns and dividends for shareholders.</p>
<div class="lb-trans"><p>Assura 是一家總部位於阿爾特林厄姆的英國房地產投資信託，目前是 EPRA* 指數的成分股，並在約翰內斯堡證券交易所有二次上市。截至 2025 年 3 月 31 日，Assura 的投資組合估值為 31 億英鎊，並在為股東創造財務回報和分紅方面有着良好的業績記錄。</p>
</div><p>At Assura we BUILD for health and as a certified B Corp we are committed to keeping ESG as the heart of our strategy, creating Healthy Environments (E), Healthy Communities (S) and maintaining a Healthy Business (G).</p>
<div class="lb-trans"><p>在 Assura，我們為健康而建設，作為一家認證的 B Corp，我們致力於將環境、社會和公司治理（ESG）作為我們戰略的核心，創造健康的環境（E）、健康的社區（S）和保持健康的商業（G）。</p>
</div><p>Further information is available at www.assuraplc.com</p>
<div class="lb-trans"><p>更多信息請訪問 www.assuraplc.com</p>
</div><p>*EPRA is a registered trademark of the European Public Real Estate Association.</p>
<div class="lb-trans"><p>*EPRA 是歐洲公共房地產協會的註冊商標。</p>
</div><p>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</p>
<div class="lb-trans"><p>此信息由 RNS 提供，倫敦證券交易所的新聞服務。RNS 獲得金融行為監管局的批准，作為英國的主要信息提供者。有關使用和分發此信息的條款和條件可能適用。如需更多信息，請聯繫 rns@lseg.com 或訪問 www.rns.com。</p>
</div><p>RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END RAGSDEFDSEISELU</p>
<div class="lb-trans"><p>RNS 可能會使用您的 IP 地址來確認您是否遵守條款和條件，分析您如何與本次溝通中包含的信息互動，並將此分析以匿名方式與他人分享，作為我們商業服務的一部分。有關 RNS 和倫敦證券交易所如何使用您提供的個人數據的更多信息，請參見我們的隱私政策。END RAGSDEFDSEISELU</p>
</div>

REG - Assura plc - 年度股東大會結果